HeartWare Implantable Pump Wins U.S. FDA Panel’s Backing

HeartWare International Inc.’s implantable pump for heart-transplant candidates won the backing of U.S. advisory panel members who said the device would provide dying patients a lifeline.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.